Clinicopathologic Diagnosis of Clear Cell Chondrosarcoma

ZHANG Hui-zhen,JIANG Zhi-ming,ZHU Xiong-zeng,SHI Lin,CHEN Jie-qing,HUANG Jin,HAN Yun-hua

DOI: https://doi.org/10.3969/j.issn.1001-7399.2007.03.016

2007-01-01

Experimental Pathology

Abstract:Purpose To investigate characteristics of clear cell chondrosarcoma (CCCS) in clinicopathology, imaging, biological behavior, and differential diagnosis. Methods There were four cases of clear cell chondrosarcoma, and their clinical data, pathologic record, and follow-up materials were collected and reviewed. Immunohistochemical stains were applied for differentiation. Results All patients were middle-aged to elderly male with long duration. All lesions were located at the epiphyses of the tubular bone. X-ray showed a bone lytic defect with sharp demarcation in the early phase and expansion progressing toward diaphyses in the late phase. The lesion did not penetrate the cortex, and there was no extraskeletal soft tissue mass. Grossly they appeared grayish white. Two of them had coexistent aneurysmal bone cysts. Microscopically, clear cells arranged in an indistinct lobular pattern characterized the tumor. The centers of the lobules contained short trabeculae of bone and osteoclast-like giant cell intermingled with the cells between the lobules. Tumor cells were well delineated with clear and vaculated cytoplasm. S-100 protein and type Ⅱ collagen were positive. Clinical treatment and follow up were shown: case 1 was recurred 6 years postoperatively. Cases 2 and 3 had tumor removal and then radiation therapy. All three cases were followed up from 2.4 years to 6 years, and currently were fine. Case 4 did right proximal femoral amputation and lost contact. Conclusions CCCS is a rare variant of low grade chondrosarcoma. The features of CCCS are different from conventional chondrosarcoma in terms of the clinical development, imaging,and pathology.In the practice,it should be differentiated from not only benign chondroblastoma and osteoblastoma,but also high grade clear cell osteosarcoma and metastatic clear cell carcinoma.